Research Groups

  • Division of biotechnological drug engineering

    The division of biotechnological drug engineering focuses on engineering and scientific challenges facing the industrialization of biotechnology drugs for the prevention and treatment of major and infectious diseases. By carrying out advanced detection and monitoring of pathogens or risk factors, drug molecular design, anti-inactivation purification and highly stable formulation screening, and preclinical research, biotechnological drugs with high quality will be obtained. Meanwhile, complete sets of equipment and integrated systems will be constructed to provide core technology and equipment support for biopharmaceutical engineering scientific research.
    Breakthrough I: The coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented effect on global health. Prof. Rui-tian Liu’s group used high-performance computer “the Sunway TaihuLight” to simulate the 3D structures and predicted the B cell epitopes on the four major structural proteins of SARS-CoV-2. Then the epitope vaccines were prepared using the well-established technology platform for rapid screening of epitope, and the epitope immunogenicity was validated by immunizing mice. These findings provide a wide neutralizing and immunodominant epitope spectrum for development of effective and safe COVID-19 vaccines (Cell Reports, 2021, 34:108666. China Patent: 202010699909.6).

    Fig. 1 Screening of novel immunodominant and neutralization linear epitopes for SARS-CoV-2.

    Breakthrough II: Prof. Songping Zhang’s group proposed a simple but effective strategy based on the specific interaction between transition metal ions and viral capsids for the stabilization of inactivated foot-and-mouth disease virus (FMDV) antigen 146S. This strategy successfully enhanced the thermostability and acid-resistant stability of 146S. And this specific interaction was further applied to purify 146S by one single-step chromatographic technology to obtain stable 146S with high purity (J Virology, 2021, 95: e02431).

    Fig. 2  Stabilization of inactivated foot-and-mouth disease virus antigen by binding with divalent transition metal ions.

    Breakthrough III: In response to the increasingly urgent need for single-cell species identification in microbial analysis for public health and biosafety, and to solve the technical difficulties at the same, Prof. Lei Zhou’s group has proposed the research idea based on trifunctional metal substrate including the “flexible charging” for bacterial enrichment, the “porous penetration” for single-cell imaging, and the “Raman enhancement” to realize bacterial identification. Then, three technical platforms have been established, which involves the selective enrichment platform for low-concentration planktonic microorganisms, total bacteria sensing and tracing platform based on nanobioprobes, and microbial species identification platform based on surface-enhanced Raman technology. Finally, the species-level identification ability for single-cell bacteria, the construction of vibrational spectroscopy database for 102 spices of bacteria, and real-time search and identification for bacteria have been achieved, respectively (ACS Sensor,2021,6: 2911-2919).

    Fig. 3  Trifunctional metal substrate (top-left), three technical platforms (lower-left), and identification of single bacteria with trifunctional metal substrate (right).

    CONTACT US

    • CONTACT US 86-10-82544817
    • CONTACT US 62551257
    • CONTACT US ghb@ipe.ac.cn
    • CONTACT US Institute of Process Engineering,Chinese Academy of Sciences,1 North 2nd Street, Zhongguancun, Haidian District, Beijing 100190, PR China